# MCRIP1

## Overview
MCRIP1, or MAPK regulated corepressor interacting protein 1, is a gene that encodes a protein involved in the regulation of gene expression, particularly in the context of lung development. The protein encoded by MCRIP1 functions as a transcriptional regulator by interacting with the C-terminal binding protein (CtBP) co-repressor, thereby modulating epigenetic gene silencing. This interaction is crucial for the expression of lung-surfactant proteins, such as SP-B and SP-C, which are essential for proper lung function and development. MCRIP1's role in disrupting CtBP-mediated repression highlights its importance in maintaining active chromatin states necessary for gene expression. The protein's activity is regulated by phosphorylation through the MAPK/ERK pathway, which influences its interaction with CtBP. Alterations in MCRIP1 expression or function have significant clinical implications, particularly in respiratory conditions like infant respiratory distress syndrome (Weng2019MCRIP1).

## Function
MCRIP1 (MAPK regulated corepressor interacting protein 1) plays a crucial role in the regulation of gene expression by interacting with the CtBP transcriptional co-repressor. In healthy human cells, MCRIP1 functions by disrupting CtBP-mediated epigenetic gene silencing, which is essential for the expression of specific genes, such as lung-surfactant proteins SP-B and SP-C. This disruption occurs through MCRIP1's ability to interfere with the interaction between CtBP and transcriptional repressors like Foxp1 and Foxp2, preventing the recruitment of CtBP to the promoters of these genes. As a result, MCRIP1 maintains these promoters in an active chromatin state, ensuring proper gene expression during lung development (Weng2019MCRIP1).

MCRIP1 is expressed in the lung epithelium from embryonic stages and continues into postnatal stages, highlighting its ongoing role in lung function. It is involved in preventing the silencing of genes necessary for lung development and function, which is critical for postnatal survival (Weng2019MCRIP1). MCRIP1 can also be phosphorylated by ERK, which inhibits its interaction with CtBP, although this phosphorylation does not occur in neonatal lungs, suggesting that MCRIP1 remains functional as a CtBP inhibitor in this context (Weng2019MCRIP1).

## Clinical Significance
Mutations or alterations in the expression of the MCRIP1 gene have significant clinical implications, particularly in respiratory conditions. MCRIP1 plays a crucial role in the expression of lung-surfactant proteins SP-B and SP-C by disrupting CtBP-mediated epigenetic gene silencing. In the absence of MCRIP1, as observed in Mcrip1 knockout mice, there is a failure to express these surfactant proteins, leading to respiratory failure at birth. This condition mirrors human infant respiratory distress syndrome (RDS), suggesting that MCRIP1 may be a potential target for mutations in hereditary RDS (Weng2019MCRIP1).

The absence of MCRIP1 results in the recruitment of CtBP to the promoters of SP-B and SP-C, causing their silencing through chromatin remodeling. This leads to impaired lung function, characterized by deflated lungs and smaller alveolar sac spaces, ultimately resulting in postnatal lethality due to respiratory failure (Weng2019MCRIP1). The study highlights the importance of MCRIP1 in preventing inappropriate gene silencing during lung development, ensuring the expression of surfactant proteins necessary for lung function and survival (Weng2019MCRIP1). These findings suggest that alterations in MCRIP1 expression or its interactions could have significant clinical implications, particularly in neonatal respiratory diseases (Weng2019MCRIP1).

## Interactions
MCRIP1 (MAPK regulated corepressor interacting protein 1) is known to interact with the transcriptional co-repressor CtBP, playing a significant role in modulating gene expression by disrupting CtBP-mediated epigenetic gene silencing. MCRIP1 binds to CtBP through a C-terminal CtBP-binding motif (PxDLS), which competitively inhibits CtBP's interaction with other proteins such as ZEB1, thereby preventing CtBP-mediated transcriptional repression of target genes (Weng2019MCRIP1). This interaction is crucial for the expression of lung-surfactant proteins SP-B and SP-C, as MCRIP1 prevents the recruitment of the CtBP co-repressor complex to their promoters, maintaining them in an active chromatin state (Weng2019MCRIP1).

MCRIP1 does not directly bind to transcriptional repressors Foxp1 and Foxp2 but competes with them for CtBP binding. This competition disrupts CtBP-mediated transcriptional repression, promoting the expression of lung surfactant proteins (Weng2019MCRIP1). In the absence of MCRIP1, CtBP1 is recruited to the promoter, leading to decreased acetylation and increased methylation of histone H3 at Lys9, which is associated with gene silencing (Weng2019MCRIP1). These interactions highlight MCRIP1's role in lung development by releasing surfactant genes from CtBP-mediated epigenetic silencing.


## References


[1. (Weng2019MCRIP1) Jane S. Weng, Takanori Nakamura, Hisashi Moriizumi, Hiroshi Takano, Ryoji Yao, and Mutsuhiro Takekawa. Mcrip1 promotes the expression of lung-surfactant proteins in mice by disrupting ctbp-mediated epigenetic gene silencing. Communications Biology, June 2019. URL: http://dx.doi.org/10.1038/s42003-019-0478-3, doi:10.1038/s42003-019-0478-3. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-019-0478-3)